RSK2 protects mice against TNF-induced bone loss. 2012

Christina Böhm, and Anja Derer, and Roland Axmann, and Ulrike Hillienhoff, and Mario M Zaiss, and Julia Luther, and Christine Zech, and Michael Stock, and Carina Scholtysek, and Klaus Engelke, and Andreas Hess, and Jan P Tuckermann, and Georg Schett, and Jean-Pierre David
Internal Medicine 3, Rheumatology and Immunology, University of Erlangen-Nuremberg, Erlangen, Germany.

Tumor necrosis factor (TNF)-α is a key cytokine regulator of bone and mediates inflammatory bone loss. The molecular signaling that regulates bone loss downstream of TNF-α is poorly defined. Here, we demonstrate that inactivating the pro-osteoblastogenic ERK-activated ribosomal S6 kinase RSK2 leads to a drastically accelerated and amplified systemic bone loss in mice ectopically expressing TNF-α [human TNF transgenic (hTNFtg) mice]. The phenotype is associated with a decrease in bone formation because of fewer osteoblasts as well as a drastically increased bone destruction by osteoclasts. The molecular basis of this phenotype is a cell autonomous increased sensitivity of osteoblasts and osteocytes to TNF-induced apoptosis combined with an enhancement of their osteoclast supportive activity. Thus, RSK2 exerts a strong negative regulatory loop on TNF-induced bone loss.

UI MeSH Term Description Entries
D008297 Male Males
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D010006 Osteoblasts Bone-forming cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone. Osteoblast
D010010 Osteoclasts A large multinuclear cell associated with the BONE RESORPTION. An odontoclast, also called cementoclast, is cytomorphologically the same as an osteoclast and is involved in CEMENTUM resorption. Odontoclasts,Cementoclast,Cementoclasts,Odontoclast,Osteoclast
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D001862 Bone Resorption Bone loss due to osteoclastic activity. Bone Loss, Osteoclastic,Osteoclastic Bone Loss,Bone Losses, Osteoclastic,Bone Resorptions,Loss, Osteoclastic Bone,Losses, Osteoclastic Bone,Osteoclastic Bone Losses,Resorption, Bone,Resorptions, Bone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal

Related Publications

Christina Böhm, and Anja Derer, and Roland Axmann, and Ulrike Hillienhoff, and Mario M Zaiss, and Julia Luther, and Christine Zech, and Michael Stock, and Carina Scholtysek, and Klaus Engelke, and Andreas Hess, and Jan P Tuckermann, and Georg Schett, and Jean-Pierre David
March 2020, Calcified tissue international,
Christina Böhm, and Anja Derer, and Roland Axmann, and Ulrike Hillienhoff, and Mario M Zaiss, and Julia Luther, and Christine Zech, and Michael Stock, and Carina Scholtysek, and Klaus Engelke, and Andreas Hess, and Jan P Tuckermann, and Georg Schett, and Jean-Pierre David
January 1992, European journal of cancer (Oxford, England : 1990),
Christina Böhm, and Anja Derer, and Roland Axmann, and Ulrike Hillienhoff, and Mario M Zaiss, and Julia Luther, and Christine Zech, and Michael Stock, and Carina Scholtysek, and Klaus Engelke, and Andreas Hess, and Jan P Tuckermann, and Georg Schett, and Jean-Pierre David
September 2012, The American journal of pathology,
Christina Böhm, and Anja Derer, and Roland Axmann, and Ulrike Hillienhoff, and Mario M Zaiss, and Julia Luther, and Christine Zech, and Michael Stock, and Carina Scholtysek, and Klaus Engelke, and Andreas Hess, and Jan P Tuckermann, and Georg Schett, and Jean-Pierre David
March 2020, Life sciences,
Christina Böhm, and Anja Derer, and Roland Axmann, and Ulrike Hillienhoff, and Mario M Zaiss, and Julia Luther, and Christine Zech, and Michael Stock, and Carina Scholtysek, and Klaus Engelke, and Andreas Hess, and Jan P Tuckermann, and Georg Schett, and Jean-Pierre David
August 2019, Nutrients,
Christina Böhm, and Anja Derer, and Roland Axmann, and Ulrike Hillienhoff, and Mario M Zaiss, and Julia Luther, and Christine Zech, and Michael Stock, and Carina Scholtysek, and Klaus Engelke, and Andreas Hess, and Jan P Tuckermann, and Georg Schett, and Jean-Pierre David
August 2022, The Journal of endocrinology,
Christina Böhm, and Anja Derer, and Roland Axmann, and Ulrike Hillienhoff, and Mario M Zaiss, and Julia Luther, and Christine Zech, and Michael Stock, and Carina Scholtysek, and Klaus Engelke, and Andreas Hess, and Jan P Tuckermann, and Georg Schett, and Jean-Pierre David
June 2018, American journal of physiology. Endocrinology and metabolism,
Christina Böhm, and Anja Derer, and Roland Axmann, and Ulrike Hillienhoff, and Mario M Zaiss, and Julia Luther, and Christine Zech, and Michael Stock, and Carina Scholtysek, and Klaus Engelke, and Andreas Hess, and Jan P Tuckermann, and Georg Schett, and Jean-Pierre David
August 2022, Biology,
Christina Böhm, and Anja Derer, and Roland Axmann, and Ulrike Hillienhoff, and Mario M Zaiss, and Julia Luther, and Christine Zech, and Michael Stock, and Carina Scholtysek, and Klaus Engelke, and Andreas Hess, and Jan P Tuckermann, and Georg Schett, and Jean-Pierre David
April 2020, Hearing research,
Christina Böhm, and Anja Derer, and Roland Axmann, and Ulrike Hillienhoff, and Mario M Zaiss, and Julia Luther, and Christine Zech, and Michael Stock, and Carina Scholtysek, and Klaus Engelke, and Andreas Hess, and Jan P Tuckermann, and Georg Schett, and Jean-Pierre David
January 2015, FEBS open bio,
Copied contents to your clipboard!